| Not Yet Recruiting | Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts Myelofibrosis, Myelofibrosis (MF) | Phase 4 | 2026-08-08 |
| Not Yet Recruiting | Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2026-08-07 |
| Not Yet Recruiting | Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 | Phase 3 | 2026-06-10 |
| Enrolling By Invitation | Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acu Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia, CD19+ Acute Leukemia | Phase 2 | 2026-05-15 |
| Not Yet Recruiting | Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams Malignant Solid Neoplasm | N/A | 2026-05-03 |
| Not Yet Recruiting | Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMI Richter Syndrome, Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma, Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Phase 3 | 2026-05-02 |
| Recruiting | Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 | Phase 3 | 2026-04-01 |
| Enrolling By Invitation | Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Head &Amp; Neck Cancer, Head &Amp; Neck Squamous Cell Carcinoma | Phase 2 | 2026-03-25 |
| Recruiting | Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Canc Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype, Lung Small Cell Carcinoma, I Subtype | Phase 2 | 2025-11-06 |
| Recruiting | Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care Colorectal Cancer Stage II, Colorectal Cancer Stage III | Phase 3 | 2025-10-15 |
| Recruiting | Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cance Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 / Phase 3 | 2025-05-22 |
| Recruiting | Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula Pancreatic Carcinoma, Pancreatic Neoplasm | Phase 3 | 2025-05-09 |
| Recruiting | Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Com Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 3 | 2024-11-27 |
| Recruiting | Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expan Lung Non-Small Cell Carcinoma | Phase 2 | 2024-11-19 |
| Recruiting | Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Exp Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2024-08-08 |
| Recruiting | Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have N AL Amyloidosis | Phase 3 | 2024-07-01 |
| Recruiting | Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BR Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 | Phase 2 | 2024-03-01 |
| Recruiting | Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant i Plasma Cell Myeloma | Phase 3 | 2023-10-12 |
| Recruiting | Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | Phase 2 | 2023-09-26 |
| Recruiting | Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 3 | 2023-09-15 |
| Recruiting | Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lym Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Phase 2 | 2023-06-12 |
| Recruiting | Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neu Malignant Solid Neoplasm | Phase 3 | 2023-06-06 |
| Recruiting | Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Ch Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2023-05-05 |
| Active Not Recruiting | Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2023-03-29 |
| Active Not Recruiting | Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 3 | 2023-03-14 |
| Active Not Recruiting | Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm | N/A | 2022-10-14 |
| Terminated | Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemothera Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | Phase 2 | 2022-08-10 |
| Withdrawn | Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2022-07-25 |
| Recruiting | Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 | Phase 2 | 2022-05-05 |
| Active Not Recruiting | Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | Phase 2 / Phase 3 | 2022-03-15 |
| Active Not Recruiting | Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for P Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm | N/A | 2021-10-12 |
| Recruiting | Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors Malignant Solid Neoplasm | — | 2021-09-13 |
| Active Not Recruiting | Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic HER2 Negative Breast Carcinoma | Phase 2 | 2021-06-08 |
| Active Not Recruiting | Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lun Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma | Phase 2 | 2021-04-16 |
| Recruiting | Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Ki Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 3 | 2021-03-08 |
| Recruiting | Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Ly Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia, Refractory T Lymphoblastic Lymphoma | Phase 1 / Phase 2 | 2021-02-08 |
| Recruiting | A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab i Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma | Phase 2 | 2021-01-06 |
| Active Not Recruiting | Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ | N/A | 2020-10-23 |
| Withdrawn | Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous C Lung Squamous Cell Carcinoma, Recurrent Lung Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2020-09-05 |
| Active Not Recruiting | A Study of miRNA 371 in Patients With Germ Cell Tumors Germ Cell Tumor, Metachronous Malignant Neoplasm, Seminoma | — | 2020-07-28 |
| Recruiting | Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8, Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 | Phase 2 | 2020-06-01 |
| Recruiting | S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Rad Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma | Phase 3 | 2020-05-04 |
| Active Not Recruiting | Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial) Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 | Phase 2 | 2020-04-08 |
| Completed | Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung C Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2020-02-14 |
| Completed | Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survi Rectal Carcinoma, Rectosigmoid Carcinoma | Phase 2 | 2020-02-10 |
| Terminated | S1916 Digital Medicine Program for Pain Control in Cancer Patients Metastatic Cancer | N/A | 2020-01-22 |
| Terminated | Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Can Hepatitis B Infection, Malignant Solid Neoplasm | Phase 3 | 2020-01-17 |
| Active Not Recruiting | S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration Multiple Myeloma | Phase 3 | 2019-08-13 |
| Completed | Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-smal Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 | Phase 2 | 2019-05-28 |
| Active Not Recruiting | Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 | — | 2019-05-14 |
| Completed | Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Loss of Heterozygosity | Phase 2 | 2019-04-16 |
| Completed | Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, Locally Advanced Thymic Carcinoma, Metastatic Thymic Carcinoma, Recurrent Thymic Carcinoma | Phase 2 | 2019-03-20 |
| Active Not Recruiting | Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery Bladder Carcinoma | Phase 3 | 2019-03-05 |
| Completed | Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnos Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Phase 3 | 2019-02-07 |
| Recruiting | Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer Previously Treated Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2019-02-06 |
| Active Not Recruiting | Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Le Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | 2018-10-24 |
| Recruiting | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prosta Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 3 | 2018-09-24 |
| Recruiting | S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative | N/A | 2018-09-17 |
| Completed | S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea | Phase 2 | 2018-06-06 |
| Completed | Lung-MAP S1400K: c-MET Positive Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 | Phase 2 | 2018-03-16 |
| Completed | Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 | Phase 2 | 2017-11-30 |
| Completed | S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma | Phase 2 | 2017-11-27 |
| Recruiting | S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain | Phase 3 | 2017-11-01 |
| Completed | Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation | Phase 2 | 2017-03-03 |
| Active Not Recruiting | S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Stage 0 Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma, Stage I Bladder Urothelial Carcinoma | Phase 3 | 2017-02-24 |
| Completed | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer | N/A | 2016-10-07 |
| Completed | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer | — | 2016-06-22 |
| Completed | S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Fo Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma | Phase 2 | 2016-01-06 |
| Active Not Recruiting | Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stag Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 | Phase 3 | 2015-12-29 |
| Active Not Recruiting | S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recu Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2015-05-07 |
| Completed | S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstructi Constipation, Impaction, and Bowel Obstruction, Unspecified Adult Solid Tumor, Protocol Specific | N/A | 2015-03-09 |
| Completed | S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorec Colorectal Cancer | Phase 2 | 2014-11-01 |
| Completed | Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Bioma Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma | Phase 2 | 2014-11-01 |
| Completed | Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous C FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification | Phase 2 / Phase 3 | 2014-10-01 |
| Completed | Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Rec CCND1 Gene Amplification, CCND2 Gene Amplification, CCND3 Gene Amplification | Phase 2 / Phase 3 | 2014-09-01 |
| Completed | S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder C Bladder Cancer | Phase 2 | 2014-08-28 |
| Terminated | S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung C Adenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer | Phase 2 | 2014-08-01 |
| Completed | Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Ca Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 | Phase 2 / Phase 3 | 2014-07-31 |
| Completed | Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lu Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 | — | 2014-07-08 |
| Terminated | Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in T MET Positive, Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7 | Phase 2 / Phase 3 | 2014-06-16 |
| Completed | S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acu Acute Leukemias of Ambiguous Lineage, B-cell Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | Phase 1 | 2014-06-13 |
| Terminated | S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Breast Cancer | Phase 3 | 2014-05-01 |
| Completed | S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2014-01-23 |
| Completed | S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 2 | 2013-10-01 |
| Active Not Recruiting | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Breast Cancer | Phase 3 | 2013-09-12 |
| Completed | S1204, Viral Screening in Newly Diagnosed Cancer Patients Cancer | — | 2013-08-29 |
| Active Not Recruiting | S0820, Adenoma and Second Primary Prevention Trial Colorectal Neoplasms | Phase 3 | 2013-08-23 |
| Completed | S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Breast Cancer, Musculoskeletal Complications, Pain | Phase 3 | 2013-05-15 |
| Completed | S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Prostate Cancer | Phase 3 | 2013-03-08 |
| Active Not Recruiting | S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly D DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma | Phase 1 / Phase 2 | 2012-11-01 |
| Completed | S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W Breast Cancer, Pain | N/A | 2012-05-16 |
| Completed | S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Bre Breast Cancer | N/A | 2012-05-01 |
| Completed | S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia Leukemia | — | 2012-04-01 |
| Completed | S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Anxiety Disorder, Breast Cancer, Cognitive/Functional Effects | N/A | 2012-03-01 |
| Completed | S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Juncti Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer | Phase 2 | 2012-02-01 |
| Completed | S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Horm Arthralgia, Breast Cancer, Pain | Phase 3 | 2012-02-01 |
| Completed | S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With S Leukemia | — | 2011-12-01 |
| Completed | S1119 Peruvian H. Pylori Water Contamination Study Helicobacter Pylori Infection | — | 2011-12-01 |
| Completed | S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Bladder Cancer | N/A | 2011-11-25 |
| Completed | S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cance Colorectal Cancer, Dermatologic Complications, Lung Cancer | — | 2011-11-15 |
| Completed | S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer | N/A | 2011-11-01 |
| Completed | S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemothe Lymphoma | Phase 2 | 2011-11-01 |
| Completed | S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia Leukemia | — | 2011-10-01 |
| Completed | S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Lymphoma | Phase 2 | 2011-09-01 |
| Completed | S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Prostate Cancer | Phase 2 | 2011-08-09 |
| Withdrawn | S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Multiple Myeloma, Plasma Cell Myeloma | Phase 2 | 2011-07-01 |
| Completed | S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabin Leukemia | — | 2011-06-01 |
| Completed | S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Kidney Cancer | Phase 3 | 2011-04-01 |
| Completed | S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients Wit Leukemia | — | 2011-03-01 |
| Completed | S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphobl Leukemia | Phase 2 | 2010-09-01 |
| Completed | S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follic Lymphoma | — | 2010-06-01 |
| Completed | S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia Leukemia | — | 2010-06-01 |
| Completed | S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treatin Breast Cancer | Phase 2 | 2010-04-01 |
| Completed | S0916, MLN1202 in Treating Patients With Bone Metastases Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | 2010-03-01 |
| Completed | S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epitheli Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2010-03-01 |
| Completed | S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Go Prostate Cancer | — | 2010-02-01 |
| Completed | S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Leukemia | Phase 2 | 2009-12-10 |
| Withdrawn | S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Re Leukemia | Phase 2 | 2009-09-01 |
| Completed | S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue | Phase 3 | 2009-09-01 |
| Terminated | S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage Recurrent Large Cell Lung Carcinoma, Recurrent Lung Adenocarcinoma, Recurrent Squamous Cell Lung Carcinoma | Phase 3 | 2009-07-15 |
| Completed | S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy Lymphoma, Nonneoplastic Condition | Phase 2 | 2009-07-01 |
| Completed | S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori) Helicobacter Pylori Infection | Phase 3 | 2009-06-01 |
| Completed | S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stag Lymphoma | Phase 2 | 2009-04-01 |
| Completed | S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lympho Lymphoma | — | 2009-04-01 |
| Completed | S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Can Colorectal Cancer | — | 2009-02-01 |
| Completed | S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Colorectal Cancer | Phase 2 | 2009-02-01 |
| Completed | S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG Breast Cancer | — | 2009-01-01 |
| Completed | S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Canc Lung Cancer | Phase 2 | 2008-12-01 |
| Completed | S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated Wit Lymphoma | — | 2008-12-01 |
| Completed | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Breast Cancer, Lung Cancer, Metastatic Cancer | — | 2008-12-01 |
| Completed | S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | 2008-12-01 |
| Completed | S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery Malignant Mesothelioma | Phase 2 | 2008-12-01 |
| Completed | S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2008-11-01 |
| Completed | S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia Leukemia | — | 2008-11-01 |
| Withdrawn | S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 Breast Cancer | — | 2008-10-01 |
| Withdrawn | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors Breast Cancer, Head and Neck Cancer, Lung Cancer | Phase 1 | 2008-09-01 |
| Withdrawn | S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autolog Lymphoma | Phase 2 | 2008-09-01 |
| Completed | S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Le Leukemia | — | 2008-08-01 |
| Completed | S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 Colorectal Cancer, Precancerous Condition | Phase 3 | 2008-06-01 |
| Completed | S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocy Leukemia | Phase 2 | 2007-11-15 |
| Completed | S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Bladder Cancer | Phase 3 | 2007-09-01 |
| Completed | S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Canc Lung Cancer | Phase 2 | 2007-07-01 |
| Completed | S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Lung Cancer | Phase 2 | 2007-07-01 |
| Completed | S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotre Leukemia | Phase 3 | 2007-06-01 |
| Completed | S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond Prostate Cancer | Phase 2 | 2007-04-01 |
| Completed | S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone Breast Cancer, Metastatic Cancer | Phase 2 | 2007-03-01 |
| Completed | S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-88 Lymphoma | — | 2007-01-01 |
| Completed | SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897 Breast Cancer | — | 2006-12-01 |
| Completed | S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacil Bladder Cancer | Phase 2 | 2006-11-01 |
| Withdrawn | S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Can Colorectal Cancer, Metastatic Cancer | Phase 2 | 2006-11-01 |
| Completed | S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Breast Cancer | Phase 3 | 2006-10-01 |
| Completed | S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Leukemia | Phase 2 | 2006-10-01 |
| Completed | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2006-09-01 |
| Completed | S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer Metastatic Cancer, Prostate Cancer | Phase 3 | 2006-08-01 |
| Completed | S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients Wi Lymphoma | Phase 2 | 2006-08-01 |
| Completed | S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313 Breast Cancer | — | 2006-07-17 |
| Completed | S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer | — | 2006-07-01 |
| Terminated | S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2006-07-01 |
| Terminated | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery Gastric Cancer | Phase 2 | 2006-05-01 |
| Withdrawn | S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spr Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer | Phase 3 | 2006-05-01 |
| Terminated | S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Can Lung Cancer | Phase 1 | 2006-04-01 |
| Terminated | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Head and Neck Cancer | Phase 3 | 2005-12-01 |
| Completed | S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage Lymphoma | Phase 2 | 2005-11-01 |
| Completed | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma Lymphoma | Phase 2 | 2005-10-01 |
| Completed | S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Dia Lung Cancer | — | 2005-10-01 |
| Completed | S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma Sarcoma | Phase 2 | 2005-09-01 |
| Completed | S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous/Nonmalignant Condition | — | 2005-09-01 |
| Completed | S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peri Lymphoma | Phase 2 | 2005-09-01 |
| Withdrawn | S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Breast Cancer | Phase 2 | 2005-09-01 |
| Terminated | S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT Prostate Cancer | — | 2005-09-01 |
| Terminated | S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Mye Multiple Myeloma | Phase 2 | 2005-08-01 |
| Completed | S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer Breast Cancer | Phase 2 | 2005-08-01 |
| Withdrawn | S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2005-07-01 |
| Terminated | S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treati Lymphoma | Phase 2 | 2005-07-01 |
| Completed | Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Sarcoma | Phase 2 | 2005-07-01 |
| Completed | S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. Breast Cancer | Phase 3 | 2005-07-01 |
| Completed | S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surg Melanoma (Skin) | Phase 2 | 2005-06-01 |
| Terminated | S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer Esophageal Cancer | Phase 2 | 2005-05-01 |
| Terminated | S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Multiple Myeloma, Plasmacytoma | Phase 2 | 2005-04-01 |
| Completed | S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Leukemia | Phase 2 | 2005-04-01 |
| Completed | SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma Lymphoma | — | 2005-03-01 |
| Completed | S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Head and Neck Cancer | Phase 2 | 2005-01-01 |
| Completed | S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone Sarcoma | Phase 2 | 2004-12-01 |
| Completed | Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer Breast Cancer | Phase 3 | 2004-12-01 |
| Completed | S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer Kidney Cancer | Phase 2 | 2004-12-01 |
| Terminated | S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women Breast Cancer | Phase 2 | 2004-11-01 |
| Completed | S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage Multiple Myeloma, Plasma Cell Neoplasm | Phase 3 | 2004-11-01 |
| Terminated | S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) Penile Cancer | Phase 2 | 2004-10-01 |
| Completed | S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Esophageal Cancer | Phase 2 | 2004-10-01 |
| Terminated | S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Wh Lung Cancer, Pulmonary Complications | N/A | 2004-09-01 |
| Completed | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or G Esophageal Cancer | Phase 2 | 2004-09-01 |
| Withdrawn | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum Colorectal Cancer | Phase 2 | 2004-08-01 |
| Completed | S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | Phase 2 | 2004-07-01 |
| Completed | S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Noth Leukemia | Phase 3 | 2004-07-01 |
| Completed | S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT Cataract, Macular Degeneration | Phase 3 | 2004-07-01 |
| Completed | S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute My Leukemia | Phase 2 | 2004-07-01 |
| Terminated | S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2004-06-01 |
| Completed | FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal C Colorectal Cancer | Phase 2 | 2004-04-01 |
| Completed | S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Br Breast Cancer | Phase 3 | 2004-04-01 |
| Terminated | S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer Lung Cancer | Phase 2 | 2004-03-01 |
| Completed | S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Lymphoma | Phase 2 | 2004-02-01 |
| Completed | S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multi Multiple Myeloma, Plasma Cell Myeloma | Phase 2 | 2004-01-01 |
| Completed | S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer Pancreatic Cancer | Phase 3 | 2004-01-01 |
| Completed | S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor Sarcoma | Phase 2 | 2003-12-01 |
| Active Not Recruiting | S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Breast Cancer | Phase 3 | 2003-11-01 |
| Completed | S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. Multiple Myeloma, Smoldering Myeloma, Waldenstrom's Macroglobulinemia | — | 2003-11-01 |
| Completed | S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Breast Cancer, Infertility, Menopausal Symptoms | Phase 3 | 2003-10-01 |
| Completed | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2003-10-01 |
| Completed | S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangi Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | 2003-09-01 |
| Completed | Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Lung Cancer | Phase 2 | 2003-09-01 |
| Completed | S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the U Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2003-07-01 |
| Completed | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors Lung Cancer | Phase 2 | 2003-07-01 |
| Terminated | S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tub Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2003-04-01 |
| Terminated | S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patien Leukemia | Phase 2 | 2003-04-01 |
| Completed | S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia Leukemia | Phase 2 | 2003-04-01 |
| Withdrawn | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer Cervical Cancer | Phase 3 | 2003-04-01 |
| Completed | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2003-04-01 |
| Terminated | S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat Head and Neck Cancer | Phase 2 | 2003-02-01 |
| Completed | S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surg Colorectal Cancer | Phase 2 | 2003-02-01 |
| Completed | S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Canc Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2003-01-01 |
| Terminated | S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cance Lung Cancer | Phase 2 | 2003-01-01 |
| Completed | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer Lung Cancer | Phase 3 | 2002-11-01 |
| Completed | S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Tre Bladder Cancer, Urethral Cancer | Phase 2 | 2002-11-01 |
| Completed | S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma Lymphoma | Phase 2 | 2002-09-01 |
| Completed | S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Breast Cancer | Phase 2 | 2002-09-01 |
| Completed | Vaccine Therapy in Treating Patients With Stage IV Melanoma Melanoma (Skin) | Phase 2 | 2002-09-01 |
| Completed | S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer Ovarian Cancer, Peritoneal Cavity Cancer | Phase 3 | 2002-08-01 |
| Completed | S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Signifi Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition | — | 2002-06-01 |
| Completed | Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Esophageal Cancer, Gastric Cancer | Phase 2 | 2002-06-01 |
| Completed | S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myelom Multiple Myeloma | Phase 2 | 2002-06-01 |
| Completed | Arsenic Trioxide in Treating Men With Germ Cell Cancer Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor | Phase 2 | 2002-04-01 |
| Completed | S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Lung Cancer | Phase 2 | 2002-01-01 |
| Terminated | S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Lung Cancer | Phase 3 | 2002-01-01 |
| Completed | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 2 | 2001-12-01 |
| Completed | S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2001-11-01 |
| Terminated | S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of Cancer-related Problem/Condition, Head and Neck Cancer, Pain | Phase 3 | 2001-11-01 |
| Completed | Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma Melanoma (Skin) | Phase 2 | 2001-11-01 |
| Terminated | S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 2001-10-01 |
| Completed | S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System | Phase 3 | 2001-09-01 |
| Completed | S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia Leukemia | Phase 2 | 2001-08-01 |
| Completed | S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome Leukemia, Myelodysplastic Syndromes | Phase 2 | 2001-08-01 |
| Completed | BMS-247550 in Treating Patients With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2001-07-01 |
| Completed | S0000 Selenium and Vitamin E in Preventing Prostate Cancer Prostate Cancer | Phase 3 | 2001-07-01 |
| Terminated | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2001-07-01 |
| Completed | BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Prostate Cancer | Phase 2 | 2001-06-01 |
| Terminated | S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer Brain Tumors, Gastric Cancer, Ovarian Cancer | Phase 1 | 2001-06-01 |
| Completed | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflamma Breast Cancer | Phase 3 | 2001-05-01 |
| Completed | S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Breast Cancer | Phase 2 | 2001-05-01 |
| Completed | Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer Kidney Cancer | Phase 2 | 2001-05-01 |
| Completed | S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus Esophageal Cancer, Gastric Cancer | Phase 2 | 2001-04-01 |
| Terminated | S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Lung Cancer | Phase 2 | 2001-03-01 |
| Completed | S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma Lymphoma | Phase 3 | 2001-03-01 |
| Completed | S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2001-03-01 |
| Completed | S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2001-02-01 |
| Completed | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, Esophageal Cancer, Gastric Cancer | Phase 2 | 2001-02-01 |
| Completed | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2000-11-01 |
| Completed | Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-sma Lung Cancer | Phase 3 | 2000-11-01 |
| Completed | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Lung Cancer | Phase 1 | 2000-10-01 |
| Terminated | S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non- Lymphoma | Phase 3 | 2000-10-01 |
| Completed | S9925: Collecting and Storing Samples From Patients With Lung Cancer Lung Cancer | — | 2000-09-01 |
| Completed | S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Melanoma (Skin) | Phase 3 | 2000-08-01 |
| Completed | S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia Leukemia | Phase 2 | 2000-07-01 |
| Completed | S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2000-06-01 |
| Terminated | S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer Breast Cancer | Phase 3 | 2000-06-01 |
| Completed | S9923 R115777 in Treating Patients With Advanced Colorectal Cancer Colorectal Cancer | Phase 2 | 2000-06-01 |
| Terminated | S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma Multiple Myeloma | Phase 3 | 2000-04-01 |
| Terminated | S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage Lymphoma | Phase 3 | 2000-04-01 |
| Completed | S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors Gastrointestinal Stromal Tumor | Phase 2 | 2000-04-01 |
| Completed | S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage Lymphoma | Phase 2 | 2000-04-01 |
| Completed | S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral St Leukemia, Myelodysplastic Syndromes | Phase 3 | 2000-02-01 |
| Completed | S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leuk Leukemia | Phase 2 | 2000-02-01 |
| Completed | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate Precancerous/Nonmalignant Condition, Prostate Cancer | Phase 3 | 2000-02-01 |
| Completed | S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Head and Neck Cancer | Phase 2 | 1999-11-01 |
| Completed | S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Pros Prostate Cancer | Phase 3 | 1999-10-15 |
| Completed | S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormon Prostate Cancer | Phase 3 | 1999-10-01 |
| Completed | S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer Lung Cancer | Phase 2 | 1999-10-01 |
| Completed | S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Lung Cancer | Phase 3 | 1999-10-01 |
| Completed | S9912 Combination Chemo in Stage III Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 1999-09-01 |
| Terminated | S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Met Melanoma (Skin), Metastatic Cancer | Phase 2 | 1999-07-01 |
| Completed | S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymph Lymphoma | Phase 2 | 1999-05-01 |
| Completed | S9804: Vinorelbine in Treating Patients With Stage IV Melanoma Melanoma (Skin) | Phase 2 | 1999-05-01 |
| Terminated | S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer Bladder Cancer | Phase 3 | 1999-04-01 |
| Completed | S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | — | 1999-04-01 |
| Completed | S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot B Malignant Mesothelioma | Phase 2 | 1999-02-01 |
| Completed | S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma Adult Meningioma | Phase 2 | 1998-11-01 |
| Completed | S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1998-10-01 |
| Completed | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer Neuroendocrine Carcinoma of the Skin | Phase 2 | 1998-10-01 |
| Completed | S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating P Lymphoma | Phase 2 | 1998-09-01 |
| Completed | S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Canc Cervical Cancer | Phase 2 | 1998-08-01 |
| Terminated | S9624 Ifosfamide in Treating Patients With Meningeal Tumors Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma | Phase 2 | 1998-07-01 |
| Completed | S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurr Breast Cancer, Psychosocial Effects of Cancer and Its Treatment | N/A | 1998-07-01 |
| Completed | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil Colorectal Cancer | Phase 2 | 1998-04-01 |
| Completed | S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer Breast Cancer, Hot Flashes | Phase 3 | 1998-04-01 |
| Completed | S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Canc Endometrial Cancer | Phase 2 | 1998-02-01 |
| Completed | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Lung Cancer | Phase 2 | 1998-02-01 |
| Terminated | SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth Head and Neck Cancer | Phase 2 | 1997-12-01 |
| Completed | S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in R Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 3 | 1997-11-01 |
| Completed | S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer Breast Cancer | — | 1997-11-01 |
| Completed | S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymph Lymphoma | — | 1997-09-15 |
| Completed | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer Pancreatic Cancer | Phase 2 | 1997-09-01 |
| Terminated | S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx Head and Neck Cancer | Phase 2 | 1997-09-01 |
| Terminated | 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer Bladder Cancer | Phase 3 | 1997-08-01 |
| Completed | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Lymphoma | Phase 3 | 1997-07-01 |
| Completed | S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1997-05-01 |
| Terminated | S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery Adrenocortical Carcinoma | Phase 2 | 1997-03-01 |
| Completed | S9630, Medroxyprogesterone in Treating Women With Breast Cancer Breast Cancer, Endometrial Cancer | Phase 3 | 1997-03-01 |
| Completed | SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial Breast Cancer, Cardiac Toxicity | — | 1997-02-01 |
| Completed | SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma Melanoma (Skin) | Phase 2 | 1996-11-01 |
| Completed | S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic M Melanoma (Skin) | — | 1996-11-01 |
| Completed | S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis Multiple Myeloma | Phase 2 | 1996-11-01 |
| Terminated | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer Breast Cancer | Phase 3 | 1996-07-01 |
| Terminated | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue Head and Neck Cancer | Phase 2 | 1996-04-01 |
| Completed | SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previ Leukemia, Neutropenia, Thrombocytopenia | Phase 2 | 1995-07-01 |
| Completed | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer Prostate Cancer | Phase 3 | 1995-05-01 |
| Completed | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patient Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 1995-05-01 |
| Completed | SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lun Lung Cancer | Phase 2 | 1995-04-01 |
| Completed | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed Colorectal Cancer | Phase 3 | 1994-12-01 |
| Completed | SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Re Lymphoma | Phase 2 | 1994-06-01 |
| Completed | SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease Lymphoma, Psychosocial Effects of Cancer and Its Treatment | — | 1994-04-01 |
| Completed | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Colorectal Cancer | Phase 3 | 1994-03-01 |
| Completed | SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma Multiple Myeloma | Phase 3 | 1994-01-01 |
| Completed | SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer Kidney Cancer | — | 1993-07-01 |
| Completed | SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma Lymphoma | — | 1993-03-01 |
| Completed | SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease Lymphoma | Phase 3 | 1992-09-01 |
| Completed | S9005 Mifepristone in Meningioma Meningioma | Phase 3 | 1992-08-01 |
| Completed | S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | — | 1991-07-01 |
| Completed | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surger Breast Cancer | Phase 3 | 1989-05-01 |
| Completed | SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma Lymphoma | — | 1989-02-01 |
| Withdrawn | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix Stage 0 Cervical Cancer, High-grade Squamous Intraepithelial Lesion | Phase 2 | — |
| Withdrawn | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx Head and Neck Cancer | Phase 2 | — |
| Withdrawn | S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer Kidney Cancer | Phase 2 | — |
| Withdrawn | S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission Breast Cancer | Phase 2 | — |
| Withdrawn | S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head an Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Squamous Cell Carcinoma of the Hypopharynx | Phase 2 | — |
| Withdrawn | S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | — |